The Pharmaceutical and Biopharmaceutical industry has the challenge of finding more innovative ways to get products to market more effectively and profitably. In this new era of global commercialisation the industry needs to overhaul their business models to improve the agility and flexibility of their organisations "go to market" strategy.
The Next Generation Pharmaceutical Summit September 2009 in Bremen, Germany, once again served as an arena for senior level executives to engage in clear and focused dialogue with their peers and examine their management objectives in a relaxed and vibrant environment.
"This has been a very, very productive meeting for me. We will be following up with frankly most of the companies that we talked to. We are very excited with the interactions and it has been a great experience."
Joseph Bolen, Chief Scientific Officer, Millennium Pharmaceuticals